• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.20% Nasdaq Down 0.17%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    127.39 Down 2.15(1.66%) May 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:129.54
    Open:129.43
    Bid:128.00 x 200
    Ask:129.50 x 300
    1y Target Est:133.33
    Beta:1.05
    Earnings Date:Jul 28 - Aug 3 (Est.)
    Day's Range:126.33 - 130.00
    52wk Range:55.36 - 133.54
    Volume:1,184,297
    Avg Vol (3m):1,555,290
    Market Cap:20.43B
    P/E (ttm):N/A
    EPS (ttm):-1.10
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    BMRNDown 1.66%20.43B
    FOLDUp 1.92%1.18B
    SHPGUp 0.67%51.02B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.87
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.15
    Quarterly EPS Est (Jun-15) :-0.53
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-2.37

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback